All posts by: Michael Zand

About Michael Zand

Feline Mesenchymal Stem Cells: What’s Known and What’s Possible – American Veterinarian

Continue reading

2018-03-29 NEWS

American Veterinarian

Feline Mesenchymal Stem Cells: What’s Known and What’s Possible
American Veterinarian
For a recent review paper, Jessica M. Quimby, DVM, PhD, DACVIM, associate professor of internal medicine in the Department of Veterinary Clinical Sciences at The Ohio State University in Columbus, and Dori L. Borjesson, BA, DVM, MPVM, PhD, professor of

Continue reading

2018-03-29 NEWS

Medscape

‘Big Deal’: NCCN Guide for Immunotherapy Adverse Events
Medscape
ORLANDO, Florida — The National Comprehensive Cancer Network (NCCN) has introduced a new guideline on immunotherapy adverse events. Immunotherapy with checkpoint inhibitors has had a huge impact on the treatment of many different types of cancer

Continue reading

2018-03-29 NEWS

Medscape

‘Big Deal’: NCCN Guide for Immunotherapy Adverse Events
Medscape
ORLANDO, Florida — The National Comprehensive Cancer Network (NCCN) has introduced a new guideline on immunotherapy adverse events. Immunotherapy with checkpoint inhibitors has had a huge impact on the treatment of many different types of cancer